subject: CHEBI:201431

object_name: B-cell lymphoma recurrent


subject: CHEBI:4031

subject_name: Cyclosporine

object_name: relapsed/refractory diffuse large B-cell lymphoma

tested_intervention: unsure


subject: CHEBI:4031

object_name: Burkitt's lymphoma refractory


subject: CHEBI:4031

object_name: B-cell lymphoma refractory


subject: CHEBI:4031

object_name: Recurrent Burkitt Lymphoma


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:3367

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Supratentorial Glioblastoma

tested_intervention: yes


subject: CHEBI:176724

subject_name: Etiracetam

object_name: spinal cord injury


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: UMLS:C3896842

object_name: adult liposarcoma


subject: UMLS:C3896842

object_name: liposarcoma


subject: UMLS:C3896842

object_name: pediatric liposarcoma


subject: UMLS:C2987342


subject: UMLS:C2987342


subject: UMLS:C2987342


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Mesothelioma


subject: MESH:C520255

object_name: mesothelial neoplasm


subject: MESH:C520255

object_name: malignant mesothelioma


subject: UNII:38RL9AE51Q

subject_name: Anifrolumab

object_name: cardiovascular disorder


subject: UNII:38RL9AE51Q

object_name: Precocious atherosclerosis


subject: UNII:IY90U61Z3S

subject_name: ARGATROBAN

object_name: Heparin-induced thrombocytopenia with thrombosis


subject: UNII:0DW7MIH1VX

subject_name: Argatroban


subject: CHEBI:48720

subject_name: argatroban


subject: CHEBI:8499

subject_name: Propranolol

object_name: fibromyalgia


subject: GTOPDB:11592

subject_name: evorpacept

object_name: Carcinoma breast stage IV


subject: CHEMBL.COMPOUND:CHEMBL4297880

subject_name: EVORPACEPT


subject: UMLS:C4329513


subject: GTOPDB:13876

subject_name: nipocalimab

object_name: juvenile dermatomyositis


subject: GTOPDB:13876

object_name: myositis


subject: GTOPDB:13876

object_name: Myositis, CTCAE 5.0


subject: UNII:87M90CV8NC

subject_name: NIPOCALIMAB


subject: UNII:87M90CV8NC


subject: UNII:87M90CV8NC


subject: UMLS:C5417823


subject: UMLS:C5417823


subject: UMLS:C5417823


subject: CHEBI:71272

subject_name: Saxagliptin


subject: UMLS:C0260090

subject_name: Liquid oxygen

object_name: acute respiratory distress syndrome


subject: UMLS:C0260090

object_name: acute lung injury


subject: UMLS:C0260090

object_name: Lung Injury


subject: UMLS:C0260090

object_name: Oxygen toxicity


subject: PUBCHEM.COMPOUND:12901617

subject_name: Ginsenoside Rg3

object_name: liver carcinoma


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: Myeloblastic leukemia


subject: UNII:7D0YB67S97

object_name: acute myelomonocytic leukemia M4


subject: UNII:7D0YB67S97

object_name: acute biphenotypic leukemia


subject: UNII:7D0YB67S97

object_name: acute leukemia of ambiguous lineage


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UMLS:C0378942


subject: UNII:9RV78Q2002

subject_name: Vedolizumab


subject: UNII:9RV78Q2002


subject: UNII:9RV78Q2002


subject: UNII:9RV78Q2002


subject: UNII:9RV78Q2002

object_name: lymphoma


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: PR:000004930

subject_name: calcineurin-binding protein cabin-1


subject: PR:000004930


subject: PR:000004930

object_name: Myelodysplasia


subject: PR:000004930

object_name: acute lymphoblastic leukemia


subject: PR:000004930

object_name: juvenile myelomonocytic leukemia


subject: PR:000004930


subject: PR:000004930


subject: PR:000004930


subject: UMLS:C1562036

subject_name: Calcineurin inhibitor


subject: UMLS:C1562036


subject: UMLS:C1562036


subject: UMLS:C1562036


subject: UMLS:C1562036


subject: UMLS:C1562036


subject: UMLS:C1562036


subject: UMLS:C1562036


subject: CHEBI:7772

subject_name: omeprazole

object_name: spinal muscular atrophy


subject: CHEBI:77260

subject_name: Omeprazole


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: septic shock


subject: UMLS:C1527137

object_name: Severe Sepsis


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C0935802

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C0935802

object_name: Embolism, Tumor


subject: UMLS:C0935802

object_name: Neoplasm Metastasis


subject: UMLS:C0935802

object_name: colorectal cancer


subject: UMLS:C0935802

object_name: colorectal carcinoma


subject: UMLS:C0935802

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Memory observations


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: PUBCHEM.COMPOUND:56841986

subject_name: Plasmalyte A

object_name: Abnormality of acid-base homeostasis


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: dense breasts


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C5544470

subject_name: Immunomodulating Agents

object_name: heart disorder


subject: UMLS:C5544470

object_name: cancer


subject: UMLS:C5544470

object_name: neoplasm


subject: CHEBI:45924

subject_name: Trimethoprim

object_name: Prevention problem


subject: CHEBI:45924

object_name: Autoimmunity


subject: CHEBI:45924

object_name: Rheumatism


subject: CHEBI:45924

object_name: connective tissue disorder


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: CHEBI:9332


subject: CHEBI:9332


subject: CHEBI:465284

subject_name: Ganciclovir

object_name: ovarian cancer


subject: CHEBI:465284

object_name: ovarian neoplasm


subject: CHEBI:465284

object_name: ovarian carcinoma


subject: CHEBI:50673

subject_name: Methimazole

object_name: Plummer disease


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Focal cortical dysplasia


subject: CHEBI:32150

object_name: liver cancer


subject: CHEBI:32150

object_name: liver neoplasm


subject: CHEBI:32150

object_name: Adult Liver Carcinoma


subject: CHEBI:32150

object_name: liver carcinoma


subject: CHEBI:32150

object_name: ototoxicity


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: UMLS:C0699595

subject_name: Septra

object_name: abscess


subject: UMLS:C4287773

subject_name: VLP-encapsulated TLR9 Agonist CMP-001

object_name: triple-negative breast carcinoma


subject: UMLS:C4287773

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:9XZ8H6N6OH

subject_name: Hydroxypropyl cellulose

object_name: dry eye syndrome


subject: UNII:9XZ8H6N6OH

object_name: Dry Eye, CTCAE


subject: UNII:9XZ8H6N6OH

object_name: Dryness of eye


subject: CHEBI:94187

subject_name: Givinostat

object_name: acquired polycythemia vera


subject: UNII:234248D0HH

subject_name: Tucatinib

object_name: colorectal neoplasm


subject: UMLS:C0672674

object_name: Acute Ischemic Stroke


subject: UMLS:C0672674

object_name: Ischemic stroke


subject: UMLS:C0672674

object_name: stroke disorder


subject: UMLS:C0672674

object_name: cerebrovascular disorder


subject: UMLS:C0672674

object_name: Stroke (heart beat)


subject: UMLS:C0672674

object_name: Stroke, CTCAE


subject: UMLS:C5706401

subject_name: Anti-TROP2 Antibody-drug Conjugate BL-M02D1

object_name: Childhood Solid Neoplasm


subject: UMLS:C5706401

object_name: Adult Solid Neoplasm


subject: UMLS:C5706401

object_name: Solid Neoplasm


subject: CHEBI:139072

object_name: Poisoning by psilocybin


subject: CHEBI:139072

object_name: Drug action (disorder)


subject: CHEBI:139072

object_name: Psilocybin causing adverse effects in therapeutic use


subject: CHEBI:139072

object_name: Dyssomnias


subject: CHEBI:139072

object_name: Sleep abnormality


subject: CHEBI:139072

object_name: Poisoning by psilocin


subject: CHEBI:139072

object_name: Mood Alteration


subject: CHEBI:139072

object_name: sleep disorder


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:8614


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: depersonalization disorder


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Severe asthma


subject: CHEBI:3723

subject_name: Citalopram


subject: PUBCHEM.COMPOUND:86294067

object_name: Diabetic peripheral neuropathy


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: Drug problem


subject: UNII:PY79D6C8RX

subject_name: Crofelemer


subject: DRUGBANK:DB16492

object_name: Coronavinae infectious disease


subject: CHEBI:6432

subject_name: Levamisole

object_name: trichuriasis


subject: CHEBI:6432

object_name: ascariasis


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Alzheimer disease type 1


subject: UNII:XX2MN88N5D

subject_name: Efalizumab

object_name: psoriatic arthritis


subject: PUBCHEM.COMPOUND:131751561

subject_name: Cyclostenol

object_name: osteoarthritis


subject: DRUGBANK:DB14276

subject_name: Turmeric


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: PUBCHEM.COMPOUND:74981710

subject_name: Bromelain


subject: UMLS:C0006217

subject_name: bromelains


subject: UMLS:C0293742

subject_name: stem bromelain


subject: MESH:C586648

subject_name: 10-valent pneumococcal conjugate vaccine

object_name: pneumococcal infection


subject: PUBCHEM.COMPOUND:135582802

subject_name: CEFTOBIPROLE MEDOCARIL

object_name: staphylococcal infection


subject: PUBCHEM.COMPOUND:135582802

object_name: Staphylococcal Skin Infections


subject: PUBCHEM.COMPOUND:135582802

object_name: skin disorder caused by infection


subject: PUBCHEM.COMPOUND:135582802

object_name: skin infection


subject: PUBCHEM.COMPOUND:135582802

object_name: skin disease caused by bacterial infection


subject: PUBCHEM.COMPOUND:135582802

object_name: cellulitis


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: UNII:N99027V28J


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: PUBCHEM.COMPOUND:135456161


subject: CHEBI:140407

subject_name: Ceftobiprole


subject: CHEBI:140407


subject: CHEBI:140407


subject: CHEBI:140407


subject: GTOPDB:12417

subject_name: abelacimab

object_name: stroke disorder


subject: GTOPDB:12417

object_name: cerebrovascular disorder


subject: GTOPDB:12417

object_name: Stroke (heart beat)


subject: GTOPDB:12417

object_name: Stroke, CTCAE


subject: UNII:KX1N4TV7UY


subject: UNII:KX1N4TV7UY


subject: UNII:KX1N4TV7UY


subject: UNII:KX1N4TV7UY


subject: UMLS:C5226842


subject: UMLS:C5226842


subject: UMLS:C5226842


subject: UMLS:C5226842


subject: UMLS:C0009905

subject_name: Contraceptives, Oral

object_name: Ligament injury


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form

object_name: bone giant cell tumor


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: mantle cell lymphoma


subject: CHEBI:173077


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Stomatitis radiation


subject: CHEBI:35176

subject_name: Zinc sulfate


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C5848866

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UMLS:C1541201

subject_name: Pegylated Paclitaxel

object_name: lymphoma


subject: UMLS:C1541201

object_name: Neoplasm Metastasis


subject: UMLS:C1541201

object_name: childhood neoplasm


subject: UMLS:C1541201

object_name: neoplastic syndrome


subject: UMLS:C1541201

object_name: cancer or benign tumor


subject: UMLS:C1541201

object_name: neoplasm


subject: UMLS:C5891112

subject_name: PLZ4-coated Paclitaxel-loaded Micelle Formulation

object_name: Recurrent Non-Muscle Invasive Bladder Carcinoma


subject: UMLS:C5891112

object_name: Stage 0a Bladder Cancer AJCC v8


subject: UMLS:C5891112

object_name: Stage I Bladder Cancer AJCC v8


subject: UMLS:C5891112

object_name: Stage 0is Bladder Cancer AJCC v8


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Thrombus


subject: CHEBI:135207

object_name: Physical trauma


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight


subject: MESH:D006495


subject: MESH:D006495

object_name: Injury


subject: MESH:D006495

object_name: Trauma


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: UMLS:C3536766


subject: PUBCHEM.COMPOUND:18943906

subject_name: Ibuprofen Ibuprofen Ibuprofen

object_name: Inflammation


subject: PUBCHEM.COMPOUND:18943906

object_name: pulpitis


subject: CHEBI:47835

subject_name: levibuprofen


subject: CHEBI:47835


subject: UNII:MT6QI8324A

subject_name: Magnesium lactate

object_name: type 2 diabetes mellitus


subject: CHEBI:3077

subject_name: Betamethasone

object_name: chronic pain (diagnosis)


subject: CHEBI:3077

object_name: Chronic pain


subject: UNII:X8R2D92QP1

subject_name: Cerliponase alfa

object_name: CLN2 disease


subject: UNII:X8R2D92QP1

object_name: neuronal ceroid lipofuscinosis 2


subject: UMLS:C0939309

subject_name: Depakote ER

object_name: cluster headache syndrome


subject: PUBCHEM.COMPOUND:135436482

subject_name: Calcium folinate

object_name: esophageal squamous cell carcinoma


subject: CHEBI:135966

subject_name: Carisbamate

object_name: herpes zoster


subject: CHEBI:135966

object_name: postherpetic neuralgia


subject: CHEBI:135966

object_name: neuralgia


subject: CHEBI:135966

object_name: Neuralgia, CTCAE


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Consent Type - Hysterectomy


subject: MESH:C553090

subject_name: Vitex agnus castus extract

object_name: breast fibrocystic disease


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Wrist Injuries


subject: CHEBI:6931

subject_name: Midazolam


subject: UMLS:C0795649

subject_name: oat bran

object_name: rheumatoid arthritis


subject: MESH:D004043

subject_name: Dietary Fiber


subject: CHEBI:18358

subject_name: Methoxsalen

object_name: mycosis fungoides


subject: UMLS:C1971343

subject_name: Injection, ranibizumab, 0.1 mg administered

object_name: Coats disease


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: Complication of transplanted liver


subject: CHEBI:5001

object_name: early-onset posterior polar cataract


subject: CHEBI:5001

object_name: pancreatic serous cystadenoma


subject: CHEBI:5001

object_name: Biliary stricture


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: sclerosing cholangitis


subject: UMLS:C0013227

object_name: primary sclerosing cholangitis


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UNII:D45TI2TWMA

object_name: Acute cerebral ischemia


subject: DRUGBANK:DB12595

subject_name: Nerinetide


subject: UMLS:C4519149


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Nephrotic Syndrome, CTCAE


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: pleural empyema


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: CHEBI:32243

subject_name: Tolfenamic acid

object_name: progressive supranuclear palsy


subject: CHEBI:91083

subject_name: Romiplostim

object_name: glioblastoma


subject: CHEBI:91083

object_name: Childhood Glioblastoma


subject: CHEBI:91083

object_name: adult glioblastoma


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: UMLS:C1505595


subject: RXCUI:135097

subject_name: Synercid

object_name: gram-positive bacterial infections


subject: CHEBI:231683

subject_name: Anakinra

object_name: familial Mediterranean fever


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:229778

object_name: adult brainstem glioma


subject: CHEBI:229778

object_name: childhood brain stem glioma


subject: CHEBI:229778

object_name: brain stem glioma


subject: CHEBI:229778

object_name: diffuse intrinsic pontine glioma


subject: UniProtKB:P0A6Z1

subject_name: HSCA_ECOLI Chaperone protein HscA (sprot)


subject: UniProtKB:P0A6Z1


subject: UniProtKB:P0A6Z1


subject: UniProtKB:P0A6Z1


subject: PR:000007702


subject: PR:000007702


subject: PR:000007702


subject: PR:000007702


subject: PR:000022925

subject_name: chaperone protein HscA


subject: PR:000022925


subject: PR:000022925


subject: PR:000022925


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: GTOPDB:4942

subject_name: GM-CSF


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0058773

subject_name: Diphtheria-Tetanus Vaccine


subject: UMLS:C0058773


subject: UMLS:C0058773


subject: UMLS:C0058773


subject: UMLS:C2703131

subject_name: CAL 101

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C2703131

object_name: adult acute myeloid leukemia


subject: UMLS:C2703131

object_name: childhood acute myeloid leukemia


subject: UMLS:C2703131

object_name: acute myeloid leukemia


subject: UMLS:C2703131

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib


subject: PUBCHEM.COMPOUND:11654566


subject: PUBCHEM.COMPOUND:11654566


subject: UMLS:C0873140

subject_name: American ginseng root

object_name: hyperglycemia


subject: UMLS:C0873140

object_name: Hyperglycemia, CTCAE


subject: UMLS:C0873140

object_name: Glucose in blood specimen above reference range


subject: CHEBI:18154

subject_name: polysaccharide


subject: CHEBI:18154


subject: CHEBI:18154


subject: CHEBI:9605

subject_name: Tirofiban

object_name: kidney failure


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: UNII:G8RGG88B68

subject_name: Peginterferon alfa-2b

object_name: melanoma


subject: UMLS:C4048752

subject_name: Ocimum tenuiflorum whole extract

object_name: Cognitive changes


subject: DRUGBANK:DB14273

subject_name: Ocimum tenuiflorum top


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat

object_name: non-small cell lung carcinoma


subject: DRUGBANK:DB11097

subject_name: Plantago seed

object_name: hereditary amyloidosis


subject: CHEBI:165446

subject_name: Psyllic acid


subject: UNII:PQX0D8J21J

object_name: breast neoplasm


subject: UMLS:C0879636


subject: MESH:C545137

subject_name: AllerSlit forte

object_name: conjunctivitis


subject: MESH:C545137

object_name: Conjunctivitis, CTCAE


subject: MESH:C545137

object_name: rhinitis


subject: MESH:C545137

object_name: Allergy


subject: MESH:C545137

object_name: History of allergies


subject: GTOPDB:9802

object_name: lupus nephritis


subject: UMLS:C4548814


subject: CHEBI:7903

subject_name: Pamidronic acid

object_name: metabolic bone disorder


subject: UMLS:C5907930

subject_name: Transcription Factor Protein SON-DP

object_name: Stomach cancer


subject: UMLS:C5907930

object_name: gastric cancer


subject: UMLS:C5907930

object_name: liver cancer


subject: UMLS:C5907930

object_name: liver neoplasm


subject: UMLS:C5907930

object_name: Adult Liver Carcinoma


subject: UMLS:C5907930

object_name: liver carcinoma


subject: UNII:C3VX249T6L

subject_name: Ravulizumab

object_name: Delayed Graft Function


subject: UMLS:C4086207


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: biliary atresia


subject: PUBCHEM.COMPOUND:9848990

subject_name: BUPRENORPHINE

object_name: post-traumatic stress disorder


subject: CHEBI:94721

subject_name: Triflusal

object_name: stroke disorder


subject: CHEBI:94721

object_name: cerebral infarction


subject: CHEBI:94721

object_name: cerebrovascular disorder


subject: MESH:D056692

subject_name: Prebiotics

object_name: multiple sclerosis


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: Immediate Postpartum Hemorrhage


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Fluid Overload


subject: CHEBI:73604

object_name: Hypervolemia


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Bladder transitional cell carcinoma stage IV


subject: CHEBI:231614

object_name: Bladder transitional cell carcinoma stage II


subject: CHEBI:231614

object_name: Bladder transitional cell carcinoma stage III


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: PR:000005225

subject_name: cell division cycle-associated 7-like protein

object_name: plasma cell myeloma


subject: CHEBI:31859

subject_name: Modafinil

object_name: Tinnitus


subject: CHEBI:31859

object_name: Tinnitus, CTCAE 5.0


subject: CHEBI:31859

object_name: Tinnitus, CTCAE 3.0


subject: CHEBI:84363

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:2376

subject_name: acarbose


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Prosthetic Valve Thrombosis


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: CHEBI:50249

subject_name: anticoagulant

object_name: blood coagulation disease


subject: UMLS:C0003280

subject_name: Anticoagulants


subject: UMLS:C3536711

subject_name: Anti-coagulant [EPC]


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:53766

subject_name: Acenocoumarol


subject: CHEBI:134975

subject_name: Fluindione


subject: UNII:Z07JR07J6C

subject_name: Namodenoson


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Blood Clot


subject: CHEBI:4466

object_name: thrombosis


subject: CHEBI:4466

object_name: Thrombosis of blood vessel


subject: CHEBI:4466

object_name: Flap necrosis


subject: CHEBI:4466

object_name: Flap ischemia


subject: UNII:7N8K34P2XH

subject_name: Detomidine

object_name: Increased reactive oxygen species production


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UNII:4A6ZWS8R8E

subject_name: PELUNTAMIG

object_name: small cell lung carcinoma


subject: UMLS:C5853679


subject: UMLS:C3467925

object_name: opioid-induced constipation


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:74067

subject_name: Ile-Ile


subject: PR:000001822

subject_name: MHC class II histocompatibility antigen gamma chain


subject: PR:000007904


subject: GTOPDB:13658

subject_name: olezarsen

object_name: cardiovascular disorder


subject: GTOPDB:13658

object_name: arteriosclerosis disorder


subject: CHEMBL.COMPOUND:CHEMBL4650438

subject_name: OLEZARSEN


subject: CHEMBL.COMPOUND:CHEMBL4650438


subject: UNII:I4965C6W4O

object_name: neuroendocrine neoplasm


subject: UNII:I4965C6W4O

object_name: non-small cell lung carcinoma


subject: UNII:I4965C6W4O

object_name: nonpapillary renal cell carcinoma


subject: UNII:I4965C6W4O

object_name: clear cell renal carcinoma


subject: UNII:I4965C6W4O

object_name: renal cell adenocarcinoma


subject: UNII:I4965C6W4O

object_name: renal cell carcinoma


subject: UNII:I4965C6W4O

object_name: Neoplasm Metastasis


subject: UNII:9566855ULN

subject_name: ISOBUTAMBEN

object_name: Symptomatic irreversible pulpitis


subject: CHEBI:6759

subject_name: Mepivacaine


subject: CHEBI:135014

subject_name: Erdosteine

object_name: Fatty Liver


subject: CHEBI:177298

object_name: Recurrent Oligodendroglioma


subject: CHEBI:177298

object_name: Recurrent Childhood Oligodendroglioma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:37924

subject_name: Atazanavir


subject: CHEBI:367163

subject_name: Darunavir


subject: UMLS:C0360032

subject_name: EMLA Cream

object_name: Algophobia


subject: CHEBI:6916

subject_name: Mexiletine

object_name: Tingling


subject: CHEBI:6916

object_name: Paresthesia, CTCAE


subject: CHEBI:6916

object_name: Paresthesia


subject: CHEBI:6916

object_name: diabetic neuropathy


subject: CHEBI:23359

subject_name: colchicine

object_name: combined hepatocellular carcinoma and cholangiocarcinoma


subject: CHEBI:23359

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:23359

object_name: Stage IIIB Hepatocellular Carcinoma AJCC v7


subject: CHEBI:23359

object_name: Hepatocellular carcinoma stage IV


subject: UMLS:C0963149

subject_name: Definity

object_name: Cardiac catheterisation as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure


subject: UMLS:C0963149

object_name: Blood Pressure Finding


subject: UMLS:C0963149

object_name: Systemic arterial pressure


subject: UMLS:C0963149

object_name: heart failure


subject: UMLS:C0963149

object_name: Heart Failure, CTCAE


subject: CHEBI:31980

subject_name: Perflutren


subject: CHEBI:31980


subject: CHEBI:31980


subject: CHEBI:31980


subject: CHEBI:31980


subject: UMLS:C1321997

subject_name: sodium chloride 3 %

object_name: trauma to the abdomen


subject: UMLS:C4329337

subject_name: TAB 001

object_name: carcinoma


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Etomidate overdose of undetermined intent


subject: PUBCHEM.COMPOUND:60708

subject_name: Raluridine

object_name: HIV infection


subject: CHEBI:5855

subject_name: Ibuprofen

object_name: Postoperative Pain, Acute


subject: CHEBI:167309

subject_name: Methadone

object_name: Acute Pain


subject: CHEBI:6801

subject_name: Metformin

object_name: Advanced Melanoma


subject: UNII:J2L7Z273SG


subject: UMLS:C5854744

subject_name: Plixorafenib


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat


subject: PUBCHEM.COMPOUND:3249

subject_name: VITAMIN D2

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:3249

object_name: coronary atherosclerosis


subject: PUBCHEM.COMPOUND:3249

object_name: coronary microvascular disorder


subject: UMLS:C3714696

subject_name: Ergocalciferol Drug Product


subject: UMLS:C3714696


subject: UMLS:C3714696


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: MESH:D000090983

subject_name: 2019-nCoV Vaccine mRNA-1273

object_name: pneumococcal infection


subject: CHEBI:135445

subject_name: Canrenone

object_name: paroxysmal atrial fibrillation


subject: PUBCHEM.COMPOUND:319260

subject_name: Phanurane


subject: UMLS:C2826152

subject_name: fluorescein sodium injection

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2826152

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C2826152

object_name: Ovarian cancer stage IV


subject: UMLS:C2826152

object_name: Stage IA Ovarian Cancer AJCC v8


subject: UMLS:C2826152

object_name: Stage IA Ovarian Cancer


subject: UMLS:C2826152

object_name: Stage I Ovarian Cancer AJCC v8


subject: UMLS:C2826152

object_name: Stage I Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2826152

object_name: fallopian tube carcinoma


subject: UMLS:C2826152

object_name: Stage II Ovarian Cancer AJCC v8


subject: UMLS:C2826152

object_name: Ovarian epithelial cancer stage II


subject: UMLS:C2826152

object_name: Stage IC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2826152

object_name: Stage IC Ovarian Cancer AJCC v8


subject: UMLS:C2826152

object_name: Stage IB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2826152

object_name: Stage IB Ovarian Cancer AJCC v8


subject: UMLS:C2826152

object_name: primary peritoneal carcinoma


subject: UMLS:C2826152

object_name: papillary serous cystadenocarcinoma


subject: UMLS:C2826152

object_name: peritoneal carcinoma


subject: UMLS:C2826152

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2826152

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2826152

object_name: Stage IIB Ovarian Cancer AJCC v8


subject: UMLS:C2826152

object_name: Ovarian cancer stage III


subject: UMLS:C2826152

object_name: Stage III Ovarian Cancer AJCC v8


subject: UMLS:C2826152

object_name: Stage IIA Ovarian Cancer AJCC v8


subject: UMLS:C2826152

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: UMLS:C2826152

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2826152

object_name: Stage IIIB Ovarian Cancer AJCC v8


subject: UMLS:C2826152

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C2826152

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C2826152

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C2826152

object_name: Stage IIIA Ovarian Cancer AJCC v8


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: acute graft versus host disease


subject: UMLS:C5783865

subject_name: GNAQ/GNA11 Antagonist DYP688

object_name: Metastatic Uveal Melanoma


subject: UMLS:C1710686

object_name: glioblastoma


subject: UMLS:C1710686

object_name: Childhood Glioblastoma


subject: UMLS:C1710686

object_name: adult glioblastoma


subject: UMLS:C1710686

object_name: Adult Giant Cell Glioblastoma


subject: UMLS:C1710686

object_name: Childhood Giant Cell Glioblastoma


subject: UMLS:C1710686

object_name: giant cell glioblastoma


subject: UMLS:C1710686

object_name: Adult Gliosarcoma


subject: UMLS:C1710686

object_name: gliosarcoma


subject: UMLS:C1710686

object_name: Childhood Gliosarcoma


subject: CHEBI:72317

subject_name: Cabozantinib


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:90881

subject_name: Camptosar

object_name: esophageal adenocarcinoma


subject: CHEBI:90881

object_name: Stage IIIB Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:90881

object_name: Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:90881

object_name: Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:90881

object_name: Stage IIIC Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:90881

object_name: Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:90881

object_name: Stage IIIA Esophageal Adenocarcinoma AJCC v7


subject: CHEBI:90881

object_name: Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8


subject: CHEBI:90881

object_name: Stage IIB Gastric Cancer AJCC v7


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:63717

subject_name: Tenofovir disoproxil

object_name: tuberculosis


subject: CHEBI:135117

subject_name: ftivazide

object_name: HIV-1 infection


subject: CHEBI:6030

subject_name: Isoniazid


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: UMLS:C5392068

subject_name: PD-L1 Inhibitors

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: uterine cervix neoplasm


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: Deep Venous Thrombosis Related to COVID-19


subject: CHEMBL.COMPOUND:CHEMBL5314348

object_name: Deep venous thrombosis


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: UMLS:C1314413


subject: CHEBI:59173

subject_name: Bivalirudin


subject: CHEBI:59173


subject: CHEBI:15365

subject_name: Aspirin

object_name: blindness


subject: CHEBI:15365

object_name: diabetic retinopathy


subject: CHEBI:44915

subject_name: Propofol

object_name: c.delivery; previous surgery, gynecological


subject: CHEBI:92769

subject_name: Iobenguane

object_name: Lewy Bodies


subject: CHEBI:92769

object_name: REM sleep behavior disorder


subject: CHEBI:92769

object_name: mild neurocognitive disorder


subject: CHEBI:92769

object_name: mild cognitive impairment


subject: CHEBI:92769

object_name: Parkinsonism


subject: CHEBI:92769

object_name: Presenile dementia


subject: CHEBI:92769

object_name: dementia


subject: CHEBI:16382

subject_name: Iodide


subject: CHEBI:16382


subject: CHEBI:16382


subject: CHEBI:16382


subject: CHEBI:16382


subject: CHEBI:16382


subject: UMLS:C5963442

subject_name: AKT1 E17K Inhibitor ALTA2618

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5963442

object_name: endometrial cancer


subject: UMLS:C5963442

object_name: uterine corpus cancer


subject: UMLS:C5963442

object_name: endometrial carcinoma


subject: UMLS:C5963442

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5963442

object_name: Embolism, Tumor


subject: UMLS:C5963442

object_name: Neoplasm Metastasis


subject: UMLS:C5963442

object_name: Childhood Breast Carcinoma


subject: UMLS:C5963442

object_name: breast carcinoma


subject: UMLS:C5963442

object_name: breast cancer


subject: UMLS:C5963442

object_name: cancer


subject: UMLS:C5963442

object_name: neoplasm


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: peripheral vascular disease


subject: CHEBI:85260

subject_name: spiramycin

object_name: cryptosporidiosis


subject: CHEBI:85260

object_name: HIV infection


subject: PUBCHEM.COMPOUND:5266

subject_name: Formacidine


subject: PUBCHEM.COMPOUND:5266


subject: KEGG.COMPOUND:C01754

subject_name: Spiramycin


subject: KEGG.COMPOUND:C01754


subject: UMLS:C0032048

subject_name: Placental Extracts

object_name: periodontitis


subject: UMLS:C0032048

object_name: Periodontal Pocket


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Recurrence


subject: UMLS:C1527137

object_name: Recurrent Malignant Neoplasm


subject: UMLS:C1527137

object_name: Recurrent disease


subject: UMLS:C1527137

object_name: Recurrent tumor


subject: UMLS:C1527137

object_name: Melasma


subject: UMLS:C1527137

object_name: Outcome of Therapy


subject: UMLS:C1527137

object_name: Best Overall Response


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:16796


subject: UMLS:C1710381

subject_name: Circadin


subject: UMLS:C1710381


subject: UMLS:C1710381


subject: UMLS:C1710381


subject: UMLS:C1710381


subject: UMLS:C1710381


subject: UMLS:C1710381


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Locally Advanced Papillary Renal Cell Carcinoma


subject: CHEBI:72317

object_name: Unresectable Renal Cell Carcinoma


subject: CHEBI:72317

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: CHEBI:72317

object_name: Stage III Renal Cell Cancer AJCC v7


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: Metastatic papillary renal cell carcinoma (disorder)


subject: CHEBI:77562

object_name: Metastatic Papillary Renal Cell Carcinoma


subject: CHEBI:77562

object_name: Papillary renal cell carcinoma type 2


subject: CHEBI:77562

object_name: hereditary papillary renal cell carcinoma


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:231369

subject_name: Savolitinib


subject: CHEBI:231369


subject: CHEBI:231369


subject: CHEBI:231369


subject: CHEBI:231369


subject: CHEBI:231369


subject: CHEBI:231369


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE

object_name: atopic conjunctivitis


subject: DRUGBANK:DB16536

subject_name: Birch bark extract

object_name: Childhood Breast Carcinoma


subject: DRUGBANK:DB16536

object_name: breast carcinoma


subject: DRUGBANK:DB16536

object_name: breast cancer


subject: DRUGBANK:DB16536

object_name: malignant neoplasm of breast staging


subject: DRUGBANK:DB16536

object_name: malignant neoplasm of breast stage I


subject: DRUGBANK:DB16536

object_name: Carcinoma breast stage I


subject: DRUGBANK:DB16536

object_name: Breast cancer stage II


subject: DRUGBANK:DB16536

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: DRUGBANK:DB16536

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: DRUGBANK:DB16536

object_name: Carcinoma breast stage IV


subject: DRUGBANK:DB16536

object_name: malignant neoplasm of breast stage IV


subject: DRUGBANK:DB16536

object_name: Breast cancer stage III


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: UMLS:C5669860


subject: CHEBI:58097

object_name: appendicitis


subject: CHEBI:58097

object_name: Appendicitis, CTCAE


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Recurrent Ependymoma


subject: PUBCHEM.COMPOUND:1805

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: UNII:QC4F7FKK7I

subject_name: Faricimab

object_name: choroidal neovascularization (physical finding)


subject: UMLS:C0021734

subject_name: Roferon-A

object_name: Metastatic Renal Cell Carcinoma


subject: UMLS:C0021734

object_name: Metastatic Renal Cell Cancer


subject: UMLS:C1655276

subject_name: T-KI


subject: UMLS:C1655276


subject: PUBCHEM.COMPOUND:122173807

subject_name: anidulafungin

object_name: neuroaspergillosis


subject: PUBCHEM.COMPOUND:122173807

object_name: Invasive pulmonary aspergillosis


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: CHEBI:10023

subject_name: Voriconazole


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Crohn disease


subject: CHEBI:231683

subject_name: Anakinra


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: UMLS:C3641749

object_name: esophageal adenocarcinoma


subject: UMLS:C3641749

object_name: lung adenocarcinoma


subject: UMLS:C3641749

object_name: cervical adenocarcinoma


subject: UMLS:C3641749

object_name: adenocarcinoma


subject: UMLS:C3641749

object_name: bile duct adenocarcinoma


subject: UMLS:C3641749

object_name: gastric adenocarcinoma


subject: UMLS:C3641749

object_name: pancreatic neoplasm


subject: UMLS:C3641749

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3641749

object_name: malignant pancreatic neoplasm


subject: UMLS:C3641749

object_name: non-small cell lung carcinoma


subject: UMLS:C3641749

object_name: colorectal cancer


subject: UMLS:C3641749

object_name: colorectal carcinoma


subject: UMLS:C3641749

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3641749

object_name: Childhood Breast Carcinoma


subject: UMLS:C3641749

object_name: breast carcinoma


subject: UMLS:C3641749

object_name: breast cancer


subject: UMLS:C0699857

subject_name: Nitrate

object_name: Senile atrophy


subject: CHEBI:17632


subject: CHEBI:48107

subject_name: Nitric acid


subject: GTOPDB:9297

subject_name: lutikizumab

object_name: rheumatoid arthritis


subject: CHEMBL.COMPOUND:CHEMBL4594518

subject_name: LUTIKIZUMAB


subject: UMLS:C5226856


subject: CHEMBL.COMPOUND:CHEMBL4298212

subject_name: RAVAGALIMAB


subject: UMLS:C5418521

subject_name: Ravagalimab


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: asthma


subject: UNII:8K80YB5GMG

subject_name: Rilonacept

object_name: Inflammation


subject: UNII:8K80YB5GMG

object_name: adult-onset Still disease


subject: UMLS:C2343505

subject_name: Arcalyst


subject: UMLS:C2343505


subject: UMLS:C1654900

subject_name: Edap

object_name: plasma cell myeloma


subject: CHEBI:90227

subject_name: Selumetinib

object_name: malignant soft tissue neoplasm


subject: CHEBI:90227

object_name: sarcoma


subject: PUBCHEM.COMPOUND:71059525

object_name: Acute Pain


subject: CHEBI:231614

subject_name: Nivolumab

object_name: In-Transit Metastasis


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:155586901

object_name: biliary tract cancer


subject: PUBCHEM.COMPOUND:155586901

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:155586901

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:155586901

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:155586901

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:155586901

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:155586901

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:155586901

object_name: bladder tumor


subject: PUBCHEM.COMPOUND:155586901

object_name: urinary bladder carcinoma


subject: PUBCHEM.COMPOUND:155586901

object_name: urinary bladder cancer


subject: PUBCHEM.COMPOUND:155586901

object_name: childhood bladder carcinoma


subject: PUBCHEM.COMPOUND:155586901

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:155586901

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:155586901

object_name: cervical cancer


subject: PUBCHEM.COMPOUND:155586901

object_name: cervical carcinoma


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ

object_name: ovarian cancer


subject: UNII:JUP57A8EPZ

object_name: ovarian neoplasm


subject: UNII:JUP57A8EPZ

object_name: ovarian carcinoma


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ


subject: UNII:JUP57A8EPZ

object_name: prostate carcinoma


subject: UNII:JUP57A8EPZ

object_name: prostate cancer


subject: UNII:JUP57A8EPZ

object_name: endometrial cancer


subject: UNII:JUP57A8EPZ

object_name: uterine corpus cancer


subject: UNII:JUP57A8EPZ

object_name: endometrial carcinoma


subject: UNII:JUP57A8EPZ

object_name: non-small cell lung carcinoma


subject: DRUGBANK:DB19218

subject_name: Camizestrant

object_name: biliary tract cancer


subject: DRUGBANK:DB19218

object_name: colorectal cancer


subject: DRUGBANK:DB19218

object_name: colorectal carcinoma


subject: DRUGBANK:DB19218

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: DRUGBANK:DB19218

object_name: pancreatic neoplasm


subject: DRUGBANK:DB19218

object_name: exocrine pancreatic carcinoma


subject: DRUGBANK:DB19218

object_name: malignant pancreatic neoplasm


subject: DRUGBANK:DB19218


subject: DRUGBANK:DB19218


subject: DRUGBANK:DB19218


subject: DRUGBANK:DB19218

object_name: bladder tumor


subject: DRUGBANK:DB19218

object_name: urinary bladder carcinoma


subject: DRUGBANK:DB19218

object_name: urinary bladder cancer


subject: DRUGBANK:DB19218

object_name: childhood bladder carcinoma


subject: DRUGBANK:DB19218

object_name: Stomach cancer


subject: DRUGBANK:DB19218

object_name: gastric cancer


subject: DRUGBANK:DB19218

object_name: cervical cancer


subject: DRUGBANK:DB19218

object_name: cervical carcinoma


subject: DRUGBANK:DB19218

object_name: prostate carcinoma


subject: DRUGBANK:DB19218

object_name: prostate cancer


subject: DRUGBANK:DB19218

object_name: endometrial cancer


subject: DRUGBANK:DB19218

object_name: uterine corpus cancer


subject: DRUGBANK:DB19218

object_name: endometrial carcinoma


subject: DRUGBANK:DB19218

object_name: non-small cell lung carcinoma


subject: UMLS:C4726586

subject_name: ADC DS-1062a

object_name: pancreatic neoplasm


subject: UMLS:C4726586

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4726586

object_name: malignant pancreatic neoplasm


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: lung disorder


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UMLS:C3273243

subject_name: Polysaccharide Vaccine

object_name: meningococcal infection


subject: UMLS:C3273243

object_name: meningitis


subject: UMLS:C3273243

object_name: Meningitis, CTCAE


subject: UMLS:C3541972

subject_name: Carbohydrate nutrients

object_name: type 2 diabetes mellitus


subject: UMLS:C3541972

object_name: Insulin resistance


subject: CHEBI:16646

subject_name: carbohydrate


subject: CHEBI:16646


subject: CHEBI:93274

subject_name: Fluvoxamine

object_name: social phobia


subject: CHEBI:93274

object_name: generalized anxiety disorder


subject: CHEBI:93274

object_name: separation anxiety disorder


subject: CHEBI:93274

object_name: Separation anxiety (finding)


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: anus disorder


subject: CHEBI:28787

object_name: anal fissure on exam (physical finding)


subject: CHEBI:28787

object_name: Anal Fissure, CTCAE


subject: CHEBI:28787

object_name: Anal fissure


subject: CHEBI:6942

subject_name: Minoxidil


subject: CHEBI:6942


subject: CHEBI:6942


subject: CHEBI:6942


subject: UMLS:C3274916

subject_name: GRASPA

object_name: Locally Advanced Pancreatic Ductal Adenocarcinoma


subject: UMLS:C3274916

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: MESH:C000627770

subject_name: folfirinox


subject: UNII:9VHD7J6363

subject_name: Livoletide

object_name: Prader-Willi syndrome


subject: UNII:9VHD7J6363

object_name: Polyphagia


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: pancreatic neoplasm


subject: CHEBI:72690

object_name: exocrine pancreatic carcinoma


subject: CHEBI:72690

object_name: malignant pancreatic neoplasm


subject: MESH:C000710692

object_name: Parkinson disease


subject: CHEBI:8499

subject_name: Propranolol

object_name: intracerebral hemorrhage


subject: CHEBI:8499

object_name: Acute Stroke


subject: CHEBI:8499

object_name: Intracranial hemorrhage


subject: CHEBI:8499

object_name: accident; vascular


subject: UMLS:C4704299

subject_name: Migraine Relief

object_name: migraine


subject: UMLS:C4704299

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C4704299

object_name: pregnancy related


subject: CHEBI:16664

subject_name: Albendazole

object_name: Anemia of pregnancy


subject: UMLS:C0721124

subject_name: Iron Supplement


subject: UMLS:C2825025

subject_name: Iron Supplement [EPC]


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Iron Overload


subject: CHEBI:75832

object_name: iron poisoning


subject: CHEBI:75832

object_name: Iron Overload, CTCAE


subject: CHEBI:29191

subject_name: hydroxyl

object_name: enterovirus infectious disease


subject: UMLS:C0700307

subject_name: hydroxyl group


subject: CHEBI:16234

subject_name: Hydroxide ion


subject: UNII:H81695M5OP

subject_name: nattokinase

object_name: Hypercholesterolemia


subject: UMLS:C0131956


subject: UNII:0JSR7Z0NB6

subject_name: Amivantamab

object_name: neoplasm of esophagus


subject: UNII:0JSR7Z0NB6

object_name: gastric neoplasm


subject: UMLS:C4085970


subject: UMLS:C4085970


subject: CHEBI:63577

subject_name: Lamivudine

object_name: Chronic hepatitis


subject: CHEBI:15365

subject_name: Aspirin

object_name: Multifocal atherosclerosis


subject: CHEBI:37941

subject_name: Clopidogrel


subject: UMLS:C4053648

subject_name: EC-18 cpd

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:7936

subject_name: Paroxetine

object_name: Primary Insomnia


subject: CHEBI:91402

subject_name: linsitinib

object_name: Small cell lung cancer recurrent


subject: UNII:15A52GPT8T

subject_name: Linsitinib


subject: CHEBI:145588

object_name: Crohn disease


subject: PUBCHEM.COMPOUND:168359761

subject_name: Chondroitin sulfate


subject: CHEBI:145591


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Acute lymphoblastic leukemia, in relapse


subject: PUBCHEM.COMPOUND:1805

object_name: Acute lymphoblastic leukemia recurrent


subject: PUBCHEM.COMPOUND:1805

object_name: Refractory Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:1805

object_name: Acute lymphoblastic leukemia with failed remission


subject: PUBCHEM.COMPOUND:1805

object_name: acute leukemia of ambiguous lineage in relapse


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: UNII:T9FVH03HMZ

subject_name: Calaspargase pegol

object_name: De Novo Myelodysplastic Syndrome


subject: UNII:T9FVH03HMZ


subject: UNII:T9FVH03HMZ

object_name: Secondary Myelodysplastic Syndrome


subject: UNII:T9FVH03HMZ


subject: UNII:T9FVH03HMZ


subject: UNII:T9FVH03HMZ


subject: UNII:T9FVH03HMZ

object_name: Treatment related acute myeloid leukaemia


subject: UNII:T9FVH03HMZ

object_name: Previously Treated Myelodysplastic Syndrome


subject: UNII:T9FVH03HMZ


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:50223

subject_name: Dexrazoxane


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:D733ET3F9O

subject_name: crisantaspase


subject: UNII:D733ET3F9O


subject: UNII:D733ET3F9O


subject: UNII:D733ET3F9O


subject: UNII:D733ET3F9O


subject: UNII:D733ET3F9O


subject: UNII:D733ET3F9O


subject: UNII:D733ET3F9O


subject: UNII:D733ET3F9O


subject: UNII:D733ET3F9O


subject: UMLS:C0591457

subject_name: Erwinase


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: UMLS:C0591457


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:229220

subject_name: Repotrectinib

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C5235281

subject_name: ALK/ROS1/NTRK/SRC/FAK Multikinase Inhibitor TPX-0005


subject: CHEBI:9168

subject_name: Sirolimus

object_name: multiple system atrophy


subject: CHEBI:61080

subject_name: Romidepsin

object_name: renal cell carcinoma


subject: UMLS:C0963679


subject: CHEBI:23965

subject_name: estradiol

object_name: vasomotor symptom


subject: PR:000012938

subject_name: pinin


subject: CHEBI:6931

subject_name: Midazolam

object_name: Inguinal hernia


subject: MESH:C000624167

subject_name: Utrogestan

object_name: Antepartum hemorrhage


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: CHEBI:5523

subject_name: Goserelin

object_name: Ovarian failure


subject: CHEBI:74947

subject_name: Thalidomide

object_name: mycobacterial infectious disease


subject: UNII:FM5526K07A

subject_name: ZINC ACETATE

object_name: Cough


subject: UNII:FM5526K07A

object_name: Cough, CTCAE


subject: PR:000001379

object_name: malignant epithelial tumor of ovary


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:135515

object_name: Recurrent ovarian cancer


subject: CHEBI:135515

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:135515

object_name: Recurrent Ovarian Carcinosarcoma


subject: CHEBI:135515

object_name: Refractory Ovarian Carcinoma


subject: CHEBI:135515

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEBI:135515

object_name: Recurrent Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEBI:135515

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEBI:135515

object_name: Refractory Female Reproductive System Carcinoma


subject: CHEBI:135515

object_name: Recurrent Female Reproductive System Carcinoma


subject: CHEBI:135515

object_name: Refractory Fallopian Tube Carcinoma


subject: CHEBI:135515

object_name: Recurrent Fallopian Tube Carcinosarcoma


subject: CHEBI:135515

object_name: Refractory Primary Peritoneal Carcinoma


subject: CHEBI:135515

object_name: Recurrent Primary Peritoneal Carcinosarcoma


subject: CHEBI:135515

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:135515

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:18258

subject_name: Liothyronine

object_name: Hypothyroidism, Autoimmune


subject: UMLS:C5784682

subject_name: MALT1 Inhibitor ONO-7018

object_name: non-Hodgkin lymphoma


subject: MESH:D003287

subject_name: Contrast Media

object_name: contrast-induced nephropathy


subject: CHEBI:3757

subject_name: Clonidine

object_name: no feeling or sensation of skin


subject: CHEBI:3757

object_name: Sensory Loss


subject: PUBCHEM.COMPOUND:152165

object_name: cystoid macular edema


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEMBL.COMPOUND:CHEMBL4650405

subject_name: LERODALCIBEP


subject: UMLS:C5446762

subject_name: Lerodalcibep


subject: CHEBI:231324

subject_name: alpelisib

object_name: endometrial cancer


subject: CHEBI:231324

object_name: uterine corpus cancer


subject: CHEBI:231324

object_name: endometrial carcinoma


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor


subject: CHEBI:50790


subject: CHEBI:50790


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UMLS:C0593802


subject: UMLS:C0593802


subject: UMLS:C3536820

subject_name: Aromatase Inhibitor [EPC]


subject: UMLS:C3536820


subject: UMLS:C3536820


subject: UMLS:C3536820

object_name: Advanced breast cancer


subject: CHEBI:74088


subject: CHEBI:74088


subject: CHEBI:74088


subject: CHEBI:74088


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:74007


subject: CHEBI:73805

subject_name: Ala-Ile


subject: CHEBI:73805


subject: CHEBI:73805


subject: CHEBI:73805


subject: UMLS:C5418057


subject: UMLS:C5418057


subject: UMLS:C5418057


subject: UMLS:C5418057

object_name: Carcinoma breast stage IV


subject: UMLS:C5418057


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: CHEBI:31924

subject_name: Albamycin

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:31924

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:28368

subject_name: Novobiocin


subject: CHEBI:28368


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Fused vertebrae


subject: UNII:E422BH4BRK

subject_name: ZILEBESIRAN

object_name: hypertension


subject: UNII:E422BH4BRK

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Pediatric Obesity


subject: UMLS:C1099192


subject: UMLS:C2931954

subject_name: MLC 901

object_name: Hypoxic ischemic encephalopathy due to cardiac arrest


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: Fatty Liver


subject: PUBCHEM.COMPOUND:57414794


subject: CHEBI:68606

subject_name: Rilpivirine


subject: CHEBI:68606


subject: PUBCHEM.COMPOUND:64987


subject: PUBCHEM.COMPOUND:64987


subject: PUBCHEM.COMPOUND:72370618

subject_name: Vemlidy


subject: PUBCHEM.COMPOUND:72370618


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:31536


subject: CHEBI:173106

subject_name: ferroptocide


subject: CHEBI:173106


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Colonic diverticula


subject: CHEBI:30011

subject_name: L-glutamine residue


subject: CHEBI:18050

subject_name: L-Glutamine


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: head and neck squamous cell carcinoma


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C4329337

subject_name: TAB 001

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: metastatic colorectal cancer


subject: PR:000017033

object_name: Periodontal Disease, CTCAE


subject: UMLS:C0074512

subject_name: Signal Recognition Particle


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: myeloproliferative syndrome


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Small Cell Lymphoma


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:7R7G6EH5UL

subject_name: Navtemadlin

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:7R7G6EH5UL

object_name: Adult Soft Tissue Sarcoma


subject: UNII:7R7G6EH5UL

object_name: sarcoma


subject: UNII:7R7G6EH5UL

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:7R7G6EH5UL

object_name: soft tissue sarcoma


subject: UNII:7R7G6EH5UL

object_name: Resectable Soft Tissue Sarcoma


subject: UMLS:C4086994

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C3273725

object_name: pancreatic neoplasm


subject: UMLS:C3273725

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3273725

object_name: malignant pancreatic neoplasm


subject: UMLS:C3273725


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UNII:PQX0D8J21J

object_name: Acute lymphoblastic leukemia recurrent


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: DRUGBANK:DB11357

subject_name: Linseed oil

object_name: neonatal abstinence syndrome


subject: DRUGBANK:DB11357

object_name: Addiction


subject: CHEBI:2677

subject_name: Augmentin

object_name: sinusitis


subject: CHEBI:2677

object_name: Sinusitis, CTCAE


subject: RXCUI:151392


subject: RXCUI:151392


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: kidney disorder


subject: PR:000005931


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:90863

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:90863

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:90863

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:90863


subject: CHEBI:90863

object_name: De Novo Myelodysplastic Syndrome


subject: CHEBI:90863

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:90863

object_name: chronic myelomonocytic leukemia


subject: CHEBI:90863

object_name: Myelodysplasia


subject: CHEBI:90863

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:90863

object_name: childhood myelodysplastic syndrome


subject: CHEBI:90863

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0752224

subject_name: Human Glandular Kallikrein 1

object_name: intracranial arteriosclerosis


subject: UMLS:C0752224

object_name: Anterior Cerebral Circulation Infarction


subject: CHEBI:31348

subject_name: Capecitabine

object_name: gallbladder adenocarcinoma


subject: CHEBI:94463

object_name: Childhood Malignant Solid Neoplasm


subject: CHEBI:94463

object_name: Malignant Solid Neoplasm


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: cancer pain


subject: CHEBI:50731

object_name: breast carcinoma


subject: CHEBI:50731

object_name: breast cancer


subject: CHEBI:50731

object_name: head and neck cancer


subject: CHEBI:50731

object_name: Wounds and Injuries


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine


subject: UNII:39IS23Q1EW


subject: UNII:39IS23Q1EW


subject: UNII:PHR838Y52L

subject_name: Troclosene

object_name: diarrhea


subject: PUBCHEM.COMPOUND:3267

subject_name: Estradiol valerate

object_name: Metrorrhagia


subject: PUBCHEM.COMPOUND:3267

object_name: heavy bleeding between periods (symptom)


subject: PUBCHEM.COMPOUND:13175121

subject_name: Dienogest


subject: PUBCHEM.COMPOUND:13175121


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: CHEBI:31348

object_name: Metastatic rectal adenocarcinoma


subject: CHEBI:31348

object_name: Locally Advanced Rectal Adenocarcinoma


subject: CHEBI:31348

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: CHEBI:191174

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:191174

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: MESH:C000629782

subject_name: talimogene laherparepvec


subject: MESH:C000629782


subject: MESH:C000629782

object_name: rectum adenocarcinoma


subject: MESH:C000629782


subject: MESH:C000629782

object_name: Stage IV Rectal Cancer AJCC v7


subject: MESH:C000629782

object_name: Stage III Rectal Cancer AJCC v7


subject: MESH:C000629782


subject: MESH:C000629782


subject: MESH:C000629782


subject: MESH:C000629782


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UMLS:C0668855

subject_name: Aflurax

object_name: Heartburn


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Leigh syndrome


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: sciatica


subject: CHEBI:41879

object_name: Sciatica due to intervertebral disc disorder


subject: CHEBI:41879

object_name: sciatic radiculopathy


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: PUBCHEM.COMPOUND:49800030

subject_name: METHYLPREDNISOLONE ACETATE


subject: PUBCHEM.COMPOUND:49800030


subject: PUBCHEM.COMPOUND:49800030


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate


subject: PUBCHEM.COMPOUND:584547


subject: PUBCHEM.COMPOUND:584547


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: PUBCHEM.COMPOUND:138713709

subject_name: deucravacitinib

object_name: ulcerative colitis


subject: PUBCHEM.COMPOUND:138713709

object_name: inflammatory bowel disease 1


subject: PUBCHEM.COMPOUND:138713709

object_name: Crohn disease


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: outcomes general quality of life


subject: UNII:5S371K6132

object_name: Perceived quality of life


subject: UNII:5S371K6132

object_name: Good quality of life


subject: CHEBI:46295

subject_name: Vardenafil

object_name: Urinary Urgency


subject: CHEBI:46295

object_name: Overactive Detrusor


subject: CHEBI:48538

subject_name: Apomorphine

object_name: Akinesia


subject: CHEBI:48538

object_name: hypomobility


subject: CHEBI:15765

subject_name: Levodopa


subject: CHEBI:15765


subject: CHEBI:27796

subject_name: Trimethobenzamide


subject: CHEBI:27796


subject: UMLS:C5418055

subject_name: Glutamine Antagonist DRP-104

object_name: fibrolamellar hepatocellular carcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:9876235

object_name: atrial fibrillation


subject: PUBCHEM.COMPOUND:9876235

object_name: Atrial Fibrillation by ECG Finding


subject: PUBCHEM.COMPOUND:9876235

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Increased reactive oxygen species production


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Disorder related to bone marrow transplantation


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4672

subject_name: Docetaxel

object_name: non-small cell lung adenocarcinoma


subject: UMLS:C5555004

subject_name: Izalontamab


subject: UMLS:C5555004

object_name: lung adenocarcinoma


subject: UMLS:C5555004

object_name: squamous cell lung carcinoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Recurrent Meningioma


subject: CHEBI:231679

object_name: grade III meningioma


subject: CHEBI:231679

object_name: grade II meningioma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:91872

object_name: Stage IV Uterine Corpus Cancer


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Local anaesthetic systemic toxicity


subject: CHEBI:23359

subject_name: colchicine

object_name: Non ST segment elevation acute coronary syndrome


subject: CHEBI:231607

subject_name: IDPN

object_name: malnutrition


subject: CHEBI:231607

object_name: Complication of hemodialysis


subject: UMLS:C1704263

subject_name: green tea extract

object_name: cancer


subject: UMLS:C1704263

object_name: neoplasm


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: PUBCHEM.COMPOUND:153563259

subject_name: FOSIGOTIFATOR

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: PUBCHEM.COMPOUND:153563259

object_name: amyotrophic lateral sclerosis


subject: DRUGBANK:DB19409

subject_name: Fosigotifator


subject: DRUGBANK:DB19409


subject: UMLS:C5240006

subject_name: Vaccine product containing only acellular Bordetella pertussis antigen (medicinal product)

object_name: poliomyelitis


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: biliary tract cancer


subject: PR:000017019

object_name: ERBB2 Gene Mutation


subject: PR:000017019

object_name: liver carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UMLS:C1831605


subject: CHEBI:174690

subject_name: Clenbuterol

object_name: heart failure


subject: CHEBI:174690

object_name: Heart Failure, CTCAE


subject: CHEBI:174690

object_name: dilated cardiomyopathy


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: hereditary methemoglobinemia


subject: UNII:T42P99266K

object_name: hemoglobin M disease


subject: UNII:T42P99266K

object_name: methemoglobinemia


subject: UNII:T42P99266K

object_name: Methemoglobinemia, CTCAE


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: UNII:C9H2L21V7U

subject_name: SMOFlipid

object_name: Developmental Psychomotor Disorders


subject: UMLS:C1134664

object_name: non-small cell lung carcinoma


subject: UMLS:C1570551

object_name: Disinhibition


subject: UMLS:C1570551

object_name: Parkinson disease


subject: UNII:6GVX9S46ZO


subject: UNII:6GVX9S46ZO


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: acute spinal cord injury


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: infant morbidity


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: CHEBI:85990

subject_name: Panobinostat

object_name: sickle cell disease


subject: CHEBI:84040

object_name: Huntington disease


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Stage III Bladder Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Stage IIIA Bladder Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Stage IIIB Bladder Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Stage II Ureter Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Stage III Ureter Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Stage II Urethral Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Stage II Renal Pelvis Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Stage III Renal Pelvis Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Stage III Urethral Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: urethra transitional cell carcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Stage II Bladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381

object_name: Muscle Invasive Bladder Carcinoma


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:25357

subject_name: mitomycin


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:25357


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:27504


subject: UMLS:C5785771

subject_name: Anti-TIGIT/Anti-PVRIG Bispecific Antibody PM1009

object_name: liver carcinoma


subject: UMLS:C5785771

object_name: Klatskin Tumor


subject: UMLS:C5785771

object_name: liver cancer


subject: UMLS:C5785771

object_name: liver neoplasm


subject: UMLS:C5785771

object_name: Adult Liver Carcinoma


subject: UMLS:C5854501

subject_name: Anti-PD-L1/Anti-VEGF-A Bispecific Antibody PM8002


subject: UMLS:C5854501


subject: UMLS:C5854501


subject: UMLS:C5854501


subject: UMLS:C0034805

subject_name: Fc Receptor

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: CHEBI:22972

subject_name: butyryl group


subject: CHEBI:22972

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:22927

subject_name: bromine atom


subject: CHEBI:22927


subject: CHEBI:22925

subject_name: bromide salt


subject: CHEBI:22925


subject: CHEBI:75929

object_name: cocaine abuse


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Progesterone Receptor Positive


subject: CHEBI:4026

object_name: Estrogen Receptor Positive


subject: CHEBI:4026

object_name: HER2 positive


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:91872

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:91872

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:91872

object_name: Breast cancer stage III


subject: CHEBI:91872

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:91872

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Progesterone Receptor Negative


subject: CHEBI:231601

object_name: Estrogen Receptor Negative


subject: CHEBI:231601

object_name: HER2/Neu Negative


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0376659

subject_name: Cancer Vaccines

object_name: adult glioblastoma


subject: UNII:15DX7Y16JB

subject_name: CARVEDILOL PHOSPHATE

object_name: Prehypertension


subject: CHEBI:3441

subject_name: Carvedilol


subject: CHEBI:6503

subject_name: LISINOPRIL


subject: CHEBI:43755

subject_name: Lisinopril


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: aortic dissection


subject: CHEBI:230430

object_name: Aortic dissection


subject: CHEBI:230430

object_name: Dissecting aortic aneurysm


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: UNII:OR3S9IF86U


subject: UNII:OR3S9IF86U


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: CHEMBL.COMPOUND:CHEMBL2108163


subject: CHEMBL.COMPOUND:CHEMBL2108163


subject: UMLS:C0077906


subject: UMLS:C0077906


subject: UMLS:C0077906


subject: UMLS:C0279328

subject_name: Hyperbaric Oxygen (substance)

object_name: Dysesthesia


subject: UMLS:C5555577

object_name: plasma cell myeloma


subject: UMLS:C5555577

object_name: adult lymphoma


subject: UMLS:C5555577

object_name: lymphoma


subject: UMLS:C5555577

object_name: pediatric lymphoma


subject: UMLS:C5555577

object_name: Oral Mucositis


subject: UMLS:C5555577

object_name: stomatitis


subject: UMLS:C5555577

object_name: oral mucositis


subject: UMLS:C5555577

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C5555577

object_name: hematopoietic and lymphoid system neoplasm


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor

object_name: cervical carcinoma


subject: MESH:C000708108

subject_name: anluohuaxian


subject: UMLS:C3274623

subject_name: Citogenex

object_name: Colon Neoplasm


subject: CHEBI:77733

subject_name: Verapamil

object_name: Mania, CTCAE


subject: CHEBI:77733

object_name: Mania


subject: UMLS:C5446895

subject_name: Anti-CTLA-4 Monoclonal Antibody IBI310

object_name: Advanced Bile Duct Carcinoma


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:19ORU63E06

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:19ORU63E06

object_name: non-Hodgkin lymphoma


subject: UNII:19ORU63E06

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:19ORU63E06

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:19ORU63E06

object_name: Lymphoma, Large-Cell, Follicular


subject: CHEBI:45783

subject_name: Imatinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:45783

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:45783

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:45783

object_name: Malignant pleural effusion


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Bone fracture


subject: CHEBI:144903

object_name: Fracture, CTCAE


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: punctate palmoplantar keratoderma type III


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: Pelvis fracture


subject: UMLS:C0016004

object_name: Hip Fracture, CTCAE


subject: UMLS:C0016004

object_name: hip fracture


subject: CHEBI:16349

subject_name: Citrulline

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:16349

object_name: obesity


subject: CHEBI:16349

object_name: Obesity, CTCAE


subject: CHEBI:16349

object_name: sarcopenia


subject: PUBCHEM.COMPOUND:164888937

subject_name: Gallium Ga 68 FAPI-46

object_name: malignant soft tissue neoplasm


subject: PUBCHEM.COMPOUND:164888937

object_name: sarcoma


subject: PUBCHEM.COMPOUND:164888937

object_name: Recurrent Sarcoma


subject: PUBCHEM.COMPOUND:164888937

object_name: Metastatic sarcoma


subject: UMLS:C5237268

subject_name: Gallium Ga 68 FAPi-46


subject: UMLS:C5237268


subject: UMLS:C5237268


subject: UMLS:C5237268


subject: UMLS:C5926468

subject_name: FAPi-46 GA-68


subject: UMLS:C5926468


subject: UMLS:C5926468


subject: UMLS:C5926468


subject: UMLS:C2587184

subject_name: Parenogen

object_name: heart valve disorder


subject: UMLS:C2587184

object_name: coronary artery disorder


subject: UMLS:C2587184

object_name: coronary atherosclerosis


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: atopy


subject: CHEBI:17650

object_name: dermatitis


subject: CHEBI:17650

object_name: Dermatitis


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Locally Advanced Unresectable Gastric Adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:91899

object_name: Wheezing


subject: CHEBI:91899

object_name: Wheezing, CTCAE


subject: CHEBI:91899

object_name: reactive airway disease


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:3207


subject: CHEBI:3207


subject: UMLS:C2714103

object_name: atopic eczema


subject: PR:000022283

subject_name: excinuclease cho

object_name: Neuroblastoma recurrent


subject: UniProtKB:P76213

subject_name: CHO_ECOLI Excinuclease cho (sprot)


subject: UMLS:C0285868

subject_name: Omnicef

object_name: Acute bacterial sinusitis


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:15355

subject_name: Acetylcholine

object_name: cardiovascular disorder


subject: CHEBI:15355

object_name: aneurysm


subject: CHEBI:57858

subject_name: atropinium


subject: CHEBI:57858


subject: CHEBI:92712

subject_name: ENDO-ATROPINE


subject: CHEBI:92712


subject: CHEBI:91541


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: UMLS:C1161352


subject: CHEBI:7514

subject_name: Neostigmine


subject: CHEBI:7514


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: musculoskeletal system disorder


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PUBCHEM.COMPOUND:136171075

subject_name: Folfirinox Regimen

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:136171075

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:136171075

object_name: malignant pancreatic neoplasm


subject: CHEBI:15365

subject_name: Aspirin

object_name: Platelet dysfunction


subject: CHEBI:7421

subject_name: NAC

object_name: pancreatic ductal adenocarcinoma


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: RXCUI:1940699

subject_name: glecaprevir / pibrentasvir Oral Product

object_name: chronic kidney disease


subject: RXCUI:1940699

object_name: Chronic Kidney Disease, CTCAE


subject: RXCUI:1940699

object_name: chronic hepatitis C virus infection


subject: UMLS:C2830052

object_name: Hepatic impairment


subject: CHEBI:91397

subject_name: Ibrutinib


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Complication of transplanted lung


subject: CHEBI:28918

object_name: lung transplant; complications, mechanical


subject: CHEBI:28918

object_name: Hemoptysis


subject: CHEBI:31308

subject_name: Brotizolam

object_name: insomnia


subject: CHEBI:31308

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:31308

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:64677

subject_name: Cerubidine

object_name: adult lymphoma


subject: CHEBI:64677

object_name: lymphoma


subject: CHEBI:64677

object_name: pediatric lymphoma


subject: UNII:DWN2WN457X

subject_name: Dexamethasone acetate monohydrate


subject: UNII:DWN2WN457X


subject: UNII:DWN2WN457X


subject: UNII:DWN2WN457X

object_name: leukemia


subject: UNII:DWN2WN457X

object_name: childhood leukemia


subject: UNII:DWN2WN457X

object_name: acute lymphoblastic leukemia


subject: UNII:DWN2WN457X

object_name: lymphoblastic lymphoma


subject: UNII:DWN2WN457X

object_name: Adult Lymphoblastic Lymphoma


subject: UNII:DWN2WN457X

object_name: Childhood Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3680

subject_name: Dexamethasone acetate


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: PUBCHEM.COMPOUND:3680


subject: UMLS:C2934194

subject_name: BI 1744 CL

object_name: liver disorder


subject: CHEBI:49668

subject_name: Gefitinib

object_name: Cushing Disease


subject: UNII:T329PCG3D4

subject_name: LACTOBACILLUS SALIVARIUS PS2

object_name: Inflammatory disorder of breast


subject: UNII:T329PCG3D4

object_name: Inflammation of non-human mammary gland


subject: UNII:T329PCG3D4

object_name: mastitis


subject: UMLS:C4721860

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:25357

subject_name: mitomycin


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: pancreatic neoplasm


subject: CHEBI:85078

object_name: exocrine pancreatic carcinoma


subject: CHEBI:85078

object_name: malignant pancreatic neoplasm


subject: CHEBI:94366

subject_name: itraconazole

object_name: Pneumonia caused by SARS-CoV-2


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: MESH:C000722724


subject: UMLS:C1170076

subject_name: Avandamet

object_name: type 2 diabetes mellitus


subject: UMLS:C2936885

subject_name: l-Thyroxine [EPC]

object_name: Hypothyroxinemia


subject: CHEBI:3441

subject_name: Carvedilol

object_name: cardiovascular disorder


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Diabetes


subject: CHEBI:9241

object_name: diabetes mellitus


subject: UNII:JYW18Y92UP

object_name: leukemia


subject: UNII:JYW18Y92UP

object_name: childhood leukemia


subject: CHEBI:35940

subject_name: Protirelin

object_name: Childhood Breast Carcinoma


subject: CHEBI:35940

object_name: breast carcinoma


subject: CHEBI:35940

object_name: breast cancer


subject: UMLS:C5557417

subject_name: Enlonstobart

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5418777

subject_name: Simmitinib


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: lower extremity diabetic ulcer


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Osteoarthritis of glenohumeral joint


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: Mesothelioma


subject: PUBCHEM.COMPOUND:135423438

object_name: mesothelial neoplasm


subject: PUBCHEM.COMPOUND:135423438

object_name: malignant mesothelioma


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:63610

subject_name: Misoprostol

object_name: cervical cancer


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: complications; renal, allograft


subject: CHEBI:74705

subject_name: Met-Leu

object_name: tuberculosis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:135983

subject_name: Teriparatide

object_name: Neuropathic spinal arthropathy


subject: UMLS:C5960828

subject_name: Anti-CD33 GSPT1 Degrader BMS-986497

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5960828

object_name: acute myeloid leukemia


subject: UMLS:C5960828

object_name: Myelodysplasia


subject: UMLS:C5960828

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C5960828

object_name: childhood myelodysplastic syndrome


subject: UMLS:C5960828

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL5314951

subject_name: SONROTOCLAX

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Refractory Grade 1 Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Refractory Grade 2 Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Nodal marginal zone B-cell lymphoma refractory


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Refractory Grade 3a Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Splenic marginal zone lymphoma refractory


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Extranodal marginal zone B-cell lymphoma (MALT type) refractory


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Splenic marginal zone lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Nodal marginal zone B-cell lymphoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Extranodal marginal zone B-cell lymphoma (MALT type) recurrent


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314951

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: UNII:30R67U9KYS

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:30R67U9KYS

object_name: Diffuse large B-cell lymphoma recurrent


subject: UNII:30R67U9KYS

object_name: Refractory Grade 1 Follicular Lymphoma


subject: UNII:30R67U9KYS

object_name: Refractory Grade 2 Follicular Lymphoma


subject: UNII:30R67U9KYS

object_name: Nodal marginal zone B-cell lymphoma refractory


subject: UNII:30R67U9KYS

object_name: Refractory Grade 3a Follicular Lymphoma


subject: UNII:30R67U9KYS

object_name: Splenic marginal zone lymphoma refractory


subject: UNII:30R67U9KYS

object_name: Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


subject: UNII:30R67U9KYS

object_name: chronic lymphocytic leukemia/small lymphocytic lymphoma


subject: UNII:30R67U9KYS

object_name: Extranodal marginal zone B-cell lymphoma (MALT type) refractory


subject: UNII:30R67U9KYS

object_name: Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


subject: UNII:30R67U9KYS

object_name: Splenic marginal zone lymphoma recurrent


subject: UNII:30R67U9KYS

object_name: Nodal marginal zone B-cell lymphoma recurrent


subject: UNII:30R67U9KYS

object_name: Extranodal marginal zone B-cell lymphoma (MALT type) recurrent


subject: UNII:30R67U9KYS

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UNII:30R67U9KYS

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UNII:30R67U9KYS

object_name: Recurrent Grade 3a Follicular Lymphoma


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: UNII:AG9MHG098Z


subject: CHEBI:74705

object_name: Postoperative hematoma


subject: CHEBI:74705

object_name: seroma as procedural complication


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318


subject: PR:000016318


subject: GTOPDB:4985

object_name: cancer


subject: GTOPDB:4985

object_name: neoplasm


subject: GTOPDB:4985

object_name: Neoplasm of uncertain or unknown behavior of kidney


subject: GTOPDB:4985

object_name: kidney benign neoplasm


subject: GTOPDB:4985

object_name: Kidney problem


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:74947


subject: CHEBI:74947


subject: KEGG.COMPOUND:C02380

object_name: colitis


subject: KEGG.COMPOUND:C02380

object_name: Colitis, CTCAE


subject: KEGG.COMPOUND:C02380

object_name: Hermansky-Pudlak syndrome


subject: KEGG.COMPOUND:C02380

object_name: lymphocyte count


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:2208


subject: UNII:FYS6T7F842

subject_name: Adalimumab


subject: UNII:FYS6T7F842


subject: UNII:FYS6T7F842


subject: UNII:FYS6T7F842


subject: CHEBI:50858

subject_name: corticosteroid


subject: CHEBI:50858


subject: CHEBI:50858


subject: CHEBI:50858


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: MESH:D000305


subject: MESH:D000305


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3540725


subject: UMLS:C3540725


subject: UMLS:C3540725


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3539185


subject: UMLS:C3539185


subject: UMLS:C3539185


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540726


subject: UMLS:C3540726


subject: UMLS:C3540726


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: UMLS:C3540727


subject: UMLS:C3540727


subject: UMLS:C3540727